301 related articles for article (PubMed ID: 20878670)
1. First-trimester Down syndrome screening: pregnant women's knowledge.
Dahl K; Hvidman L; Jørgensen FS; Henriques C; Olesen F; Kjaergaard H; Kesmodel US
Ultrasound Obstet Gynecol; 2011 Aug; 38(2):145-51. PubMed ID: 20878670
[TBL] [Abstract][Full Text] [Related]
2. Knowledge of prenatal screening and psychological management of test decisions.
Dahl K; Hvidman L; Jørgensen FS; Kesmodel US
Ultrasound Obstet Gynecol; 2011 Aug; 38(2):152-7. PubMed ID: 20954167
[TBL] [Abstract][Full Text] [Related]
3. Effects of knowledge, education, and experience on acceptance of first trimester screening for chromosomal anomalies.
Stefansdottir V; Skirton H; Jonasson K; Hardardottir H; Jonsson JJ
Acta Obstet Gynecol Scand; 2010 Jul; 89(7):931-8. PubMed ID: 20235896
[TBL] [Abstract][Full Text] [Related]
4. Women's opinions on the offer and use of nuchal translucency screening for Down syndrome.
Müller MA; Bleker OP; Bonsel GJ; Bilardo CM
Prenat Diagn; 2006 Feb; 26(2):105-11. PubMed ID: 16463289
[TBL] [Abstract][Full Text] [Related]
5. The provision of information and informed decision-making on prenatal screening for Down syndrome: a questionnaire- and register-based survey in a non-selected population.
Schoonen M; Wildschut H; Essink-Bot ML; Peters I; Steegers E; de Koning H
Patient Educ Couns; 2012 Jun; 87(3):351-9. PubMed ID: 22030253
[TBL] [Abstract][Full Text] [Related]
6. How important is consent in maternal serum screening for Down syndrome in France? Information and consent evaluation in maternal serum screening for Down syndrome: a French study.
Favre R; Duchange N; Vayssière C; Kohler M; Bouffard N; Hunsinger MC; Kohler A; Mager C; Neumann M; Vayssière C; Viville B; Hervé C; Moutel G
Prenat Diagn; 2007 Mar; 27(3):197-205. PubMed ID: 17238219
[TBL] [Abstract][Full Text] [Related]
7. Expectation and knowledge of women undergoing first-trimester combined screening for Down syndrome in a Chinese population.
Chan LW; Chau MC; Leung TY; Fung TY; Leung TN; Lau TK
Prenat Diagn; 2005 Dec; 25(13):1248-52. PubMed ID: 16353273
[TBL] [Abstract][Full Text] [Related]
8. Do pregnant women in Greece make informed choices about antenatal screening for Down's syndrome? A questionnaire survey.
Gourounti K; Sandall J
Midwifery; 2008 Jun; 24(2):153-62. PubMed ID: 17316936
[TBL] [Abstract][Full Text] [Related]
9. Pregnant women's attitudes toward amniocentesis before receiving Down syndrome screening results.
Brajenović-Milić B; Babić I; Ristić S; Vraneković J; Brumini G; Kapović M
Womens Health Issues; 2008; 18(2):79-84. PubMed ID: 18180167
[TBL] [Abstract][Full Text] [Related]
10. A survey of the knowledge and attitudes of pregnant Thai women towards Down syndrome screening.
Pruksanusak N; Suwanrath C; Kor-Anantakul O; Prasartwanakit V; Leetanaporn R; Suntharasaj T; Hanprasertpong T
J Obstet Gynaecol Res; 2009 Oct; 35(5):876-81. PubMed ID: 20149035
[TBL] [Abstract][Full Text] [Related]
11. [Pregnant women's assessment and level of knowledge of prenatal counseling].
Tschudin S; Holzgreve W; Conde N; Alder J; Bitzer J; Tercanli S
Ultraschall Med; 2009 Apr; 30(2):157-62. PubMed ID: 18484059
[TBL] [Abstract][Full Text] [Related]
12. 'This is just what you do when you are pregnant': a qualitative study of prospective parents in Iceland who accept nuchal translucency screening.
Gottfredsdóttir H; Sandall J; Björnsdóttir K
Midwifery; 2009 Dec; 25(6):711-20. PubMed ID: 18295382
[TBL] [Abstract][Full Text] [Related]
13. First trimester predictors of adverse pregnancy outcomes.
Brameld KJ; Dickinson JE; O'Leary P; Bower C; Goldblatt J; Hewitt B; Murch A; Stock R
Aust N Z J Obstet Gynaecol; 2008 Dec; 48(6):529-35. PubMed ID: 19133038
[TBL] [Abstract][Full Text] [Related]
14. Women's perception of information and experiences of nuchal translucency screening in Greece.
Gourounti K; Lykeridou K; Daskalakis G; Glentis S; Sandall J; Antsaklis A
Fetal Diagn Ther; 2008; 24(2):86-91. PubMed ID: 18648204
[TBL] [Abstract][Full Text] [Related]
15. Audiovisual information affects informed choice and experience of information in antenatal Down syndrome screening--a randomized controlled trial.
Björklund U; Marsk A; Levin C; Öhman SG
Patient Educ Couns; 2012 Mar; 86(3):390-5. PubMed ID: 21807474
[TBL] [Abstract][Full Text] [Related]
16. Are pregnant Australian women well informed about prenatal genetic screening? A systematic investigation using the Multidimensional Measure of Informed Choice.
Rowe HJ; Fisher JR; Quinlivan JA
Aust N Z J Obstet Gynaecol; 2006 Oct; 46(5):433-9. PubMed ID: 16953859
[TBL] [Abstract][Full Text] [Related]
17. Informed choice in women attending private clinics to undergo first-trimester screening for Down syndrome.
Jaques AM; Sheffield LJ; Halliday JL
Prenat Diagn; 2005 Aug; 25(8):656-64. PubMed ID: 16049990
[TBL] [Abstract][Full Text] [Related]
18. [A qualitative study of pregnant women's choice of nuchal translucency measurement].
Lou S; Dahl K; Risør MB; Hvidman LE; Thomsen SG; Jørgensen FS; Olesen F; Kjaergaard H; Kesmodel U
Ugeskr Laeger; 2007 Mar; 169(10):914-8. PubMed ID: 17359736
[TBL] [Abstract][Full Text] [Related]
19. Factors affecting mothers' knowledge of genetic screening.
Suriadi C; Jovanovska M; Quinlivan JA
Aust N Z J Obstet Gynaecol; 2004 Feb; 44(1):30-4. PubMed ID: 15089865
[TBL] [Abstract][Full Text] [Related]
20. Informed decision-making in prenatal screening for Down's syndrome: what knowledge is relevant?
Schoonen HM; van Agt HM; Essink-Bot ML; Wildschut HI; Steegers EA; de Koning HJ
Patient Educ Couns; 2011 Aug; 84(2):265-70. PubMed ID: 20800415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
